Decoy Therapeutics Begins Trading Under DCOY
Decoy Therapeutics (formerly Salarius Pharmaceuticals) will begin trading on Nasdaq under ticker DCOY on January 8, 2026, the company announced January 7, 2026. The preclinical-stage biotech says its proprietary peptide-conjugate platform and AI-enabled discovery infrastructure will accelerate candidate selection as it advances a lead antiviral program with BARDA interest toward IND-enabling work, while pursuing partnerships and non-dilutive funding in a capital-efficient 2026 plan.
Scoring Rationale
Official company rebrand with BARDA interest and AI-enabled platform boosts credibility and relevance, but limited technical detail limits novelty.
Practice interview problems based on real data
1,500+ SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problems
